Atrion Corp. (ATRI) - Company Projected Revenue

Corporate company logo of Atrion Corporation (ATRI)

Geopolitical instability and raw material logistics disruptions are increasing costs for Atrion Corporation (ATRI), limiting exports. The company's target sales volumes visualize the impact of these factors, where the 0.18 mark indicates the current state. A mature portfolio of ophthalmology solutions provides stability, while synergy with cardiac centers through the customization of consumables optimizes supply chains.

Atrion Corporation - ATRI Projected Sales Volume (period 07/04/2022 - 08/31/2024)

Summary analytical data breakdowns for Atrion Corporation Inc. (ATRI)

- current price and projected stock value:
Summary company analytics:Atrion Corporation ATRI
Brand item of Atrion Corp

Atrion Corporation maintains stability through patent protection and stringent FDA standards in cardiology. This indicator captures expected operating revenues based on current contracts, eliminating quarterly reporting lags. It is critical for investors to monitor demand dynamics to identify anomalous market spikes in a timely manner. High switching costs for hospitals make this forecast particularly reliable. By analyzing the company's future sales trajectory, one can assess the resilience of the asset's fundamental value.

Key competitors

Company Future Sales Volume ISRG (Intuitive Surgical)|DHR (Danaher Corp) - Company Future Revenue|BD - Company Future Sales Volume|Projected Sales Volume STERIS Group STE|WST - Company Projected Revenue|Baxter International (BAX) - Company Future Sales Volume|Masimo Corp (MASI) - Company Projected Revenue|Company Future Sales Volume Stevanato Group|Company Projected Revenue Teleflex Incorporated|Company Expected Sales Volume Merit Medical Corp MMSI|Company Projected Revenue Envista (NVST)|ICU Medical - Company Revenue Forecast|DENTSPLY SIRONA Inc. - Company Future Sales Volume|Company Projected Revenue Volume LMAT (LeMaitre Vascular Inc)|ATRC - Company Projected Revenue|Company Future Sales STAAR Surgical Co STAA|NAGE: Projected Sales Volume|Company Expected Revenue ZIMV (ZimVie Inc.)|Company Projected Revenue AngioDynamics Corp|Company Expected Sales Volume Cerus Corp. CERS|Company Projected Revenue Teknova (TKNO)|Monogram Orthopedics Inc. - Company Revenue Forecast|Company Projected Revenue Sharps Technology, Inc. STSS|Projected Sales Volume InfuSystem Holdings INFU|UTMD: Company Future Sales Volume|Company Future Revenue KRMD (KORU Medical)|NYXH: Projected Sales Volume|MBOT (Microbot Medical, Inc) - Company Projected Revenue|Company Future Sales Volume PDEX|ZTEK: Company Future Revenue|Projected Sales Volume ELUT|Milestone Scientific Inc. - Company Revenue Forecast|Company Projected Revenue NEXGEL, Inc. NXGL|Retractable Tech - Company Projected Revenue|harvardbioscience.com - Projected Sales Volume|FEMY (Femasys Inc.) - Company Revenue Forecast|MHUA: Projected Sales Volume|Predictive Oncology Corp - Company Future Revenue|CJMB (Callan JMB) - Projected Sales Volume|NURO: Company Future Revenue